ARCHIVES

$1.5 Million In Direct Costs Is Proposed Core Grant Requirement

This article is from The Cancer Letter archive.

Vol. 17 No. 28 | July 12, 1991

Download PDF Visit The Full Archive

Related Articles

In Brief: NIDDK Begins BPH Trial; Roswell Park Honors Schwarzkopf; NRC Cites MIT

March 1, 1996

NCI Cooperative Group Clinical Trials Approved

September 25, 2009

Organization Can Compete For Both Major FCRC Contracts, RFP Out Next June

September 12, 1980

Cancer Genetics: risk from Three BRCA Mutations Lower Than Expected, NCI Finds

May 23, 1997

‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’

September 20, 1991

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008